These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 27272371)

  • 1. A methadone user with anaemia, skeletal pain and altered appearance.
    Kaur P; Bergrem A; Gerlyng P; Reims HM; Leh S; Valeur J
    Tidsskr Nor Laegeforen; 2016 Jun; 136(10):925-9. PubMed ID: 27272371
    [No Abstract]   [Full Text] [Related]  

  • 2. Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users.
    Ganesan S; Felo J; Saldana M; Kalasinsky VF; Lewin-Smith MR; Tomashefski JF
    Mod Pathol; 2003 Apr; 16(4):286-92. PubMed ID: 12692192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Crospovidone: A Newly Described Foreign Body Due to Illicit Drug Abuse.
    Hoyt BS; Aaron DM; Yan S; Linos KD
    Am J Dermatopathol; 2019 Aug; 41(8):e84-e86. PubMed ID: 31335429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Povidone hypersensitivity--extremely unusual or underestimated? The pharmaceutic aid povidone was earlier not considered toxic or allergenic].
    Ekman E; Werkström V; Vinge E; Hansson C
    Lakartidningen; 2007 Apr 25-May 1; 104(17):1318-9. PubMed ID: 17547277
    [No Abstract]   [Full Text] [Related]  

  • 5. Urticaria and anaphylaxis to povidone in a paracetamol preparation.
    Bergendorff O; Hansson C
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):573-4. PubMed ID: 17374012
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel basophil activation test in the diagnosis of povidone anaphylaxis.
    Murthee KG; Varese N; Hew M; O'Hehir RE; Zubrinich C
    Ann Allergy Asthma Immunol; 2021 Jan; 126(1):98-99. PubMed ID: 32911058
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary miliaria: caused by thesaurismosis or allergy?].
    Duverne J; Volle H; Perret MJ; Lagnier H; Bérard J
    J Fr Med Chir Thorac; 1971 Jan; 25(1):69-73. PubMed ID: 5553090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness, tolerance and acceptance of polyvidon preparations].
    Höh H; Fink R; Dehnicke C; Klöcker N
    Klin Monbl Augenheilkd; 1999 Oct; 215(4):A8-14. PubMed ID: 10572880
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a successful ICSI programme without the use of PVP.
    Butler EA; Masson GM
    Hum Reprod; 1997 May; 12(5):1115-6. PubMed ID: 9194679
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a successful ICSI programme without the use of PVP.
    Cho YS; Traina V; Boyer P
    Hum Reprod; 1997 May; 12(5):1116-7. PubMed ID: 9194680
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous crospovidone reaction secondary to subcutaneous injection of buprenorphine.
    Marka A; Hoyt BS; Dagrosa AT; Barton DT; Kim A; Linos K; Yan S
    J Cutan Pathol; 2020 May; 47(5):470-474. PubMed ID: 31804714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Police interference with methadone treatment in Bangkok, Thailand.
    Hayashi K; Ti L; Kaplan K; Suwannawong P; Wood E; Kerr T
    Int J Drug Policy; 2015 Jan; 26(1):112-5. PubMed ID: 25239286
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaphylaxis to povidone in a child.
    Pedrosa C; Costa H; Oliveira G; Romariz J; Praça F
    Pediatr Allergy Immunol; 2005 Jun; 16(4):361-2. PubMed ID: 15943602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyvinylpyrrolidone deposition disease in patients with intravenous opioid use: a case series.
    Leh F; Stalund IV; Bjånes TK; Ohldieck C; Svarstad E; Leh S
    Hum Pathol; 2021 Oct; 116():102-111. PubMed ID: 34329652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Methadone in Induction and/or Exacerbation of Cluster Headache in Patients Treated for Opioid Addiction.
    Diot C; Eiden C; Leglise Y; Donnadieu-Rigole H; Peyrière H
    Therapie; 2015; 70(3):305-7. PubMed ID: 25487851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis to polyvinylpyrrolidone in an analgesic preparation.
    Rönnau AC; Wulferink M; Gleichmann E; Unver E; Ruzicka T; Krutmann J; Grewe M
    Br J Dermatol; 2000 Nov; 143(5):1055-8. PubMed ID: 11069520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users.
    Zhao L; Holzemer WL; Johnson M; Tulsky JP; Rose CD
    AIDS Care; 2012; 24(2):195-203. PubMed ID: 21780984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
    Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
    Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylactic shock following povidone.
    Gonzalo Garijo MA; Durán Quintana JA; Bobadilla González P; Máiquez Asuero P
    Ann Pharmacother; 1996 Jan; 30(1):37-40. PubMed ID: 8773164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.